Site icon Business Manchester

Brian Tenner Steps Down as CEO of Nanoco

brian tenner steps down as ceo of nanoco business manchester

Nanoco has revealed significant changes in its leadership. CEO Brian Tenner has announced his departure, signalling a new chapter for the tech company.

Tenner, who has been at the helm since September 2020, plans to remain until a successor is appointed. This shift comes as part of a wider executive reshuffle within Nanoco.

CEO Brian Tenner’s Departure

Nanoco, a leading tech company specialising in cadmium-free quantum dots, announced today the impending departure of CEO Brian Tenner. This move comes as a part of broader executive changes within the company.

Brian Tenner joined Nanoco in 2018 and became the CEO in September 2020. He will continue in his role until a successor is found and will assist during the transition period.

Changes in Leadership

Dr Chris Richards, the current Chairman of Nanoco, had already expressed his intention to leave at the next AGM. However, he has decided to stay on until a new CEO is appointed to ensure a smooth transition.

The search for a new CEO is already underway. The new leader will be expected to focus on further developing the company’s commercial traction.

Acknowledgements and Contributions

Dr Richards thanked Brian Tenner for his leadership through challenging times, including the settlement of litigation with Samsung. “The Board is grateful to Brian for leading the business through challenging times,” Richard said.

Brian Tenner’s leadership saw the company achieve significant milestones, including boosting shareholder returns and solidifying the company’s financial position. These achievements provide a strong foundation for the future.

“On behalf of everyone at Nanoco, the Board thanks Brian for his substantial contribution and wishes him and his family all the best for the future,” Dr Richards added.

Future Prospects for Nanoco

With a solid cash position and recent technological advancements, the company is in a strong position to move forward. The incoming CEO will have the foundation needed to focus on driving commercial success.

Dr Richards emphasised the importance of the company’s strong cash position, which was bolstered by the successful litigation settlement. This financial stability is expected to underpin future growth.

Company Background

Nanoco is a spin-out from the University of Manchester and is a leader in nanomaterials research. The company has been pivotal in the development of cadmium-free quantum dots, used in various high-tech applications.

Recently, Nanoco launched a new tech facility in Runcorn, aiming to further its research and commercial output.

The company continues to push the boundaries of nanotechnology, making significant contributions to the field and maintaining a competitive edge in the market.

Quotes from Brian Tenner

Brian Tenner shared his thoughts on his departure: “I have been honoured to lead the talented team at Nanoco. The transition period is a good moment to start the process of identifying the successful candidate and handing the baton on.”

Tenner also highlighted the achievements during his tenure and expressed optimism for Nanoco’s future. “The transition to a period in which a successor can focus squarely on the commercial development of the company is a good moment to start,” he said.

Executive Transitions

Executive transitions can be challenging, but Nanoco appears well-prepared for this change. The planned handover period aims to ensure continuity and stability.

Such transitions often involve a detailed process of identifying and recruiting a qualified successor. Nanoco is already in the midst of this process, looking for a leader who can drive the company forward.


The departure of Brian Tenner marks a significant transition for Nanoco. With a strong foundation and robust leadership search, the company is poised for future success.

The search for a new CEO is ongoing, ensuring the continuity and stability of Nanoco during this period of change.

Nanoco’s impressive strides in nanotechnology and financial health provide a promising outlook for its future developments.

Exit mobile version